Abstract
Two patients with nephrotic syndrome developed fatal fulminant hepatitis B following withdrawal of prednisolone or cyclophosphamide. Immunosuppressive therapy probably enhanced hepatitis B virus (HBV) replication and widespread infection of hepatocytes; its withdrawal permitted a return of immune competence resulting in massive destruction of infected hepatocytes. Prior screening of all patients for hepatitis B surface antigen, gradual withdrawal of immunosuppressive drugs with careful monitoring, and prompt intervention with corticosteroids at the first clinical or biochemical signs of liver cell damage may prevent this complication.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brzosko W. J., Krawczyński K., Nazarewicz T., Morzycka M., Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet. 1974 Aug 31;2(7879):477–482. doi: 10.1016/s0140-6736(74)92012-1. [DOI] [PubMed] [Google Scholar]
- Fakunle Y. M., Abdurrahman M. B., Whittle H. C. Hepatitis-B virus infection in children and adults in Northern Nigeria: a preliminary survey. Trans R Soc Trop Med Hyg. 1981;75(5):626–629. doi: 10.1016/0035-9203(81)90133-4. [DOI] [PubMed] [Google Scholar]
- Galbraith R. M., Eddleston A. L., Williams R., Zuckerman A. J. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet. 1975 Sep 20;2(7934):528–530. doi: 10.1016/s0140-6736(75)90897-1. [DOI] [PubMed] [Google Scholar]
- Kibukamusoke J. W., Hutt M. S., Wilks N. E. The nephrotic syndrome in Uganda and its association with quartan malaria. Q J Med. 1967 Jul;36(143):393–408. [PubMed] [Google Scholar]
- Lewis G. P., Jusko W. J., Graves L., Burke C. W. Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971 Oct 9;2(7728):778–780. doi: 10.1016/s0140-6736(71)92738-3. [DOI] [PubMed] [Google Scholar]
- Nagy J., Bajtai G., Brasch H., Süle T., Ambrus M., Deák G., Hamori A. HBsaG in renal disease. Lancet. 1978 Aug 5;2(8084):315–316. doi: 10.1016/s0140-6736(78)91716-6. [DOI] [PubMed] [Google Scholar]
- Obineche E. N., Awunor-Renner C. The role of hepatitis B surface antigen (HBsAg) in acute glomerulonephritis in adults. East Afr Med J. 1981 May;58(5):341–343. [PubMed] [Google Scholar]
- TAYLOR R. D., CORCORAN A. C., PAGE I. H. Treatment of the nephrotic syndrome with nitrogen mustard. J Lab Clin Med. 1950 Dec;36(6):996–997. [PubMed] [Google Scholar]
- Thung S. N., Gerber M. A., Klion F., Gilbert H. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med. 1985 Jul;145(7):1313–1314. [PubMed] [Google Scholar]
- Wands J. R. Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy. Lancet. 1975 Nov 15;2(7942):979–979. doi: 10.1016/s0140-6736(75)90391-8. [DOI] [PubMed] [Google Scholar]